% | $
Quotes you view appear here for quick access.

Response Genetics, Inc. Message Board

bucksave1 2 posts  |  Last Activity: Aug 5, 2015 11:27 AM Member since: Jan 11, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to


    by lvstations Aug 5, 2015 11:04 AM
    bucksave1 bucksave1 Aug 5, 2015 11:27 AM Flag

    what r u talkg about?

  • Radhakrishnan, Karthik,

    Warma and the board got a numbers guy with jobs lasting no more than 2 to 5 years.
    If rad so good why take a job at this little biotech and not something better like building a bridge or a car engine, etc. " EASY WAY OUT "

    Mr. Karthik Radhakrishnan, CFA, has been appointed as Chief Financial Officer of OPEXA THERAPEUTICS, INC., effective March 29, 2013. Mr. Radhakrishnan has served as Chief Financial Officer since March 2013. Prior to joining Opexa, Mr. Radhakrishnan was most recently a Vice President at ING Investment Management in New York. While at ING from 2007 to 2012, he was responsible for healthcare investments in the small & small-mid cap core/growth products that are part of the Fundamental Equity product line. Previously, Mr. Radhakrishnan was the senior analyst at Eagle Asset Management from 2005 to 2007, responsible for large cap growth healthcare, and he served in various analyst positions including Senior Analyst at The Dow Chemical Company where he worked from 2002 to 2005. Mr. Radhakrishnan served as a member of the Board of Trustees at Cares Foundation, a non-profit organization serving the Congenital Adrenal Hyperplasia community, from 2008 to 2011. Mr. Radhakrishnan is a CFA charter holder and has an MBA degree from the University of Michigan, a Masters in Engineering from the State University of New York and a Bachelor’s degree from the Indian Institute of Technology.

0.0250.000(0.00%)Aug 10 3:59 PMEDT